SE409323B - Anvendning av en optisk isomer av bi-(4,5,6,7-tetrahydronaftyl)-fosforsyraderivat for kemisk upplosning av basiska optiska cis- och trans-isomerer - Google Patents

Anvendning av en optisk isomer av bi-(4,5,6,7-tetrahydronaftyl)-fosforsyraderivat for kemisk upplosning av basiska optiska cis- och trans-isomerer

Info

Publication number
SE409323B
SE409323B SE7203303A SE330372A SE409323B SE 409323 B SE409323 B SE 409323B SE 7203303 A SE7203303 A SE 7203303A SE 330372 A SE330372 A SE 330372A SE 409323 B SE409323 B SE 409323B
Authority
SE
Sweden
Prior art keywords
afthyl
tetrahydrone
isomers
trans
phosphoric acid
Prior art date
Application number
SE7203303A
Other languages
English (en)
Swedish (sv)
Inventor
R Viterbo
J Jacques
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of SE409323B publication Critical patent/SE409323B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Braiding, Manufacturing Of Bobbin-Net Or Lace, And Manufacturing Of Nets By Knotting (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
SE7203303A 1971-03-18 1972-03-15 Anvendning av en optisk isomer av bi-(4,5,6,7-tetrahydronaftyl)-fosforsyraderivat for kemisk upplosning av basiska optiska cis- och trans-isomerer SE409323B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT49167/71A IT951631B (it) 1971-03-18 1971-03-18 Composti utili per la separazione di isomeri ottici geometrici e strutturali e relativo procedimen to di sintesi

Publications (1)

Publication Number Publication Date
SE409323B true SE409323B (sv) 1979-08-13

Family

ID=11269830

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7203303A SE409323B (sv) 1971-03-18 1972-03-15 Anvendning av en optisk isomer av bi-(4,5,6,7-tetrahydronaftyl)-fosforsyraderivat for kemisk upplosning av basiska optiska cis- och trans-isomerer

Country Status (18)

Country Link
US (1) US3848030A (cg-RX-API-DMAC10.html)
JP (1) JPS5547013B1 (cg-RX-API-DMAC10.html)
AU (1) AU462431B2 (cg-RX-API-DMAC10.html)
BE (1) BE780887A (cg-RX-API-DMAC10.html)
CA (1) CA961500A (cg-RX-API-DMAC10.html)
CH (1) CH576921A5 (cg-RX-API-DMAC10.html)
DE (1) DE2212660C3 (cg-RX-API-DMAC10.html)
DK (1) DK139944B (cg-RX-API-DMAC10.html)
ES (1) ES400862A1 (cg-RX-API-DMAC10.html)
FR (1) FR2129741A5 (cg-RX-API-DMAC10.html)
GB (1) GB1360946A (cg-RX-API-DMAC10.html)
IL (1) IL38860A (cg-RX-API-DMAC10.html)
IT (1) IT951631B (cg-RX-API-DMAC10.html)
NL (1) NL7203574A (cg-RX-API-DMAC10.html)
NO (1) NO136357C (cg-RX-API-DMAC10.html)
PH (1) PH10768A (cg-RX-API-DMAC10.html)
SE (1) SE409323B (cg-RX-API-DMAC10.html)
ZA (1) ZA721297B (cg-RX-API-DMAC10.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4143028A (en) * 1977-12-05 1979-03-06 Ciba-Geigy Corporation Alkylated 1,1'-biphenyl-2,2'-diyl phosphonites and stabilized compositions
US5288914A (en) * 1984-08-27 1994-02-22 The Dow Chemical Company Poly(arylcyclobutenes)
NL8403224A (nl) * 1984-10-24 1986-05-16 Oce Andeno Bv Dioxafosforinanen, de bereiding ervan en de toepassing voor het splitsen van optisch actieve verbindingen.
DE3940765A1 (de) * 1989-12-09 1991-06-13 Hoechst Ag Verfahren zur herstellung reiner cyclischer phosphorsaeurediarylester
ES2149357T3 (es) * 1994-05-16 2000-11-01 Merrell Pharma Inc Procedimiento y sales diastereomeras utiles para la resolucion optica del acido 4-(4-((hidroxidifenilmetil)-1-piperidinil)-1-hidroxibutil)-alfa,alfa-dimetilbenceno acetico racemico.
JP4725757B2 (ja) * 1999-03-24 2011-07-13 東ソー株式会社 ビナフトールリン酸誘導体及びその利用
DE60008807T2 (de) 1999-03-24 2005-01-13 Tosoh Corp., Shinnanyo Binaphtol-monophosphorsäurederivate und deren Verwendung
ATE320420T1 (de) 1999-10-22 2006-04-15 Takeda Pharmaceutical Verfahren zur herstellung von optisch aktiven naphthalinderivaten und darin eingesetzte optische resolver
CA2390921A1 (en) * 1999-11-10 2001-05-17 Hiroyuki Tawada Process for the production of optically active cyclic enaminone derivative
US6391926B2 (en) 2000-03-13 2002-05-21 Tosoh Corporation Optically active phosphate derivative
EP1411916B1 (en) 2001-07-09 2008-08-27 Repros Therapeutics Inc. Methods and materials for the treatment of testosterone deficiency in men
WO2004096753A1 (ja) * 2003-04-25 2004-11-11 Toagosei Co., Ltd. キラルなブレンステッド酸による不斉合成用触媒および当該触媒を用いた不斉合成方法
US7229557B2 (en) * 2004-02-04 2007-06-12 Konec, Inc. Method to separate stereoisomers
EP2486032A4 (en) * 2009-10-09 2013-03-27 Hetero Research Foundation RACEMATSPALTUNG SUBSTITUTED 2- (2-PYRIDINYLMETHYLSULFINYL) -1H-BENZIMIDAZOLE
UA113291C2 (xx) 2011-08-04 2017-01-10 Метаболіти транскломіфену і їх застосування
JP2015527360A (ja) 2012-08-21 2015-09-17 レプロス セラピューティクス インコーポレイティド トランス−クロミフェン製剤およびその使用
CN104994877A (zh) 2012-11-02 2015-10-21 利普生物药剂公司 用于癌症治疗的反式-克罗米芬
CA2942301A1 (en) * 2014-03-11 2015-09-17 Repros Therapeutics Inc. Clomiphene synthesis using a single solvent
KR20170040797A (ko) 2014-07-24 2017-04-13 아스펜 파크 파마슈티컬스 인코포레이티드 시스-클로미펜을 이용하여 안드로겐 박탈 요법 유발된 일과성 열감 및 골 소실을 치료하는 방법
EP3015454A1 (en) * 2014-10-28 2016-05-04 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Stable solid form of trans-Clomiphene citrate
EP3015453B1 (en) 2014-10-28 2016-10-12 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of Clomiphene
WO2017182097A1 (en) 2016-04-22 2017-10-26 F.I.S. - Fabbrica Italiana Sintetici S.P.A. Process for the preparation of enclomiphene citrate having needle shaped crystal habit.
KR20240155974A (ko) 2017-09-11 2024-10-29 아토사 테라퓨틱스, 인크. 엔독시펜을 제조 및 사용하는 방법
FR3082842A1 (fr) * 2018-06-21 2019-12-27 Veru Inc. Polymorphe de cis-clomiphene (zuclomiphene) et procedes d'utilisation de celui-ci
AU2020300624A1 (en) 2019-07-03 2022-02-03 Atossa Therapeutics, Inc. Sustained release compositions of endoxifen
CA3098552A1 (en) 2019-11-14 2021-05-14 Apotex Inc. Processes for the preparation of zuclomiphene and intermediates thereof
CA3098725A1 (en) 2019-11-14 2021-05-14 Apotex Inc. Zuclpomiphene salts and crystalline forms thereof
CA3105944A1 (en) 2020-01-22 2021-07-22 Apotex Inc. Crystalline forms of zuclomiphene citrate
EP3907213A1 (en) 2020-05-04 2021-11-10 Pcas Processes for the production of isomerically pure or enriched cis-clomiphene
US11578025B2 (en) 2020-10-19 2023-02-14 Apotex Inc. Processes for the preparation of zuclomiphene intermediates

Also Published As

Publication number Publication date
DE2212660B2 (de) 1980-07-10
NL7203574A (cg-RX-API-DMAC10.html) 1972-09-20
NO136357B (cg-RX-API-DMAC10.html) 1977-05-16
AU3961172A (en) 1973-09-06
JPS5547013B1 (cg-RX-API-DMAC10.html) 1980-11-27
IT951631B (it) 1973-07-10
DE2212660C3 (de) 1981-09-24
US3848030A (en) 1974-11-12
IL38860A (en) 1975-06-25
FR2129741A5 (cg-RX-API-DMAC10.html) 1972-10-27
CH576921A5 (cg-RX-API-DMAC10.html) 1976-06-30
PH10768A (en) 1977-09-05
AU462431B2 (en) 1975-06-09
CA961500A (en) 1975-01-21
ZA721297B (en) 1973-03-28
GB1360946A (en) 1974-07-24
DK139944C (cg-RX-API-DMAC10.html) 1979-10-22
DE2212660A1 (de) 1972-09-28
BE780887A (fr) 1972-07-17
NO136357C (no) 1977-08-24
DK139944B (da) 1979-05-21
ES400862A1 (es) 1976-04-16
IL38860A0 (en) 1972-04-27

Similar Documents

Publication Publication Date Title
SE409323B (sv) Anvendning av en optisk isomer av bi-(4,5,6,7-tetrahydronaftyl)-fosforsyraderivat for kemisk upplosning av basiska optiska cis- och trans-isomerer
SU698518A3 (ru) Устройство дл насыщени крови кислородом
NO144418C (no) Fremgangsmaate til fremstilling av klorerte etenderivater
SE7803860L (sv) Forfarande for framstellning av 7-d-(-)-alfa-amino-alfa(p-hydroxifenylacetamido)desacetoxicefalosporansyra
NO138615C (no) Anvendelse av et amin for fremstilling av vandige, stabile opploesninger av 1,2-benzisotiazolon
SE397677B (sv) Forfarande for framstellning av en alfa-dipeptidlagalkylester av l-asparaginsyra
NO147917C (no) Fremgangsmaate for fremstilling av 3-metyl-delta3-cefem-4-karboksylsyre-forbindelser
SE416302B (sv) Forfarande for framstellning av foreningar tillhorande dihydrolysergsyra- och dihydroisolysergsyraserien
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
NO144170C (no) Fremgangsmaate til fremstilling av desacetoksy-cefalosporansyrederivater.
IT961234B (it) Coloranti basici e procedimento per la loro preparazione
SE396964B (sv) Forfarande for kristallisering av fruktos
SE373666B (sv) Metcell for metning av vetskors konduktivitet
NO147644C (no) Fremgangsmaate for fremstilling av 6-amino-penicillansyre
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
NO147600C (no) Fremgangsmaate til fremstilling av tereftalsyre.
NO140736C (no) Fremgangsmaate til fremstilling av poly-alfa-oksyakrylsyre
NO763231L (no) Fremgangsm}te til fremstilling av 6beta,17-dihydroksy-7alfa-(lavere alkoksy)karbonyl-3-okso-17alfa-pregn-4-en-21-karboksylsyre gamma-laktoner.
NO140135C (no) Fremgangsmaate for fremstilling av d(-)-penicillamin og salter av dette
NO144488C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater
SE396599B (sv) Forfarande for framstellning av 1,2-di-substituerade hydraziner
SE7508489L (sv) Forfarande och anordning for vermebehandling av staltrad.
NO138635C (no) Hjoerneforbindelse, samt fremgangsmaate for fremstilling av slik